Paper5776026
Biphasic development of carrageenin edema in rats.
Vinegar R and 2 others. J Pharmacol Exp Ther, 1969. Cited by 545 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biphasic development of carrageenin edema in rats. Papers, record 5776026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5776026
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrageenan | Major topic |
| Edema | Major topic |
| Animals | |
| Aspirin | |
| Body Temperature | |
| Foot | |
| Hydrocortisone | |
| Indomethacin | |
| Male | |
| Phenylbutazone | |
| Rats | |
| Skin | |
| Time Factors |
Source PubMed
Cited by188
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 545 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,783,892 | Resolution-Phase Immunometabolic Reprogramming by Gelidiopsis variabilis Polysaccharides: Macrophage Polarization and In Vivo Anti-Inflammatory Efficacy. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42783892 | PubMed |
| 42,534,351 | Pharmacological Assessment of Calamus guruba Methanolic Extract: Multitarget Effects on Diabetes, Inflammation, Anxiety, and Depression. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42534351 | PubMed |
| 42,513,156 | Chemical Characterization and Anti-Inflammatory Activity of Eugenia involucrata Essential Oil: Evidence from In Vitro and In Vivo Experimental Models. | Molecules | 2026 | https://conductscience.org/library/papers/42513156 | PubMed |
| 42,502,765 | Investigating the Anti-inflammatory Mechanism of Alpinia purpurata (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation. | Iran J Pharm Res | 2026 | https://conductscience.org/library/papers/42502765 | PubMed |
| 41,465,877 | In Vivo Assessment of Anti-Inflammatory Effects of Aqueous Extracts of Nepeta nuda ssp. nuda L. in Experimental Model of Peripheral Inflammation in Male Long Evans Rats. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41465877 | PubMed |
| 41,194,974 | Colocasia Esculenta as a Potential Plant-Based Medicine: A Review on Its Bioactive Constituents and Pharmacological Activities. | J Exp Pharmacol | 2025 | https://conductscience.org/library/papers/41194974 | PubMed |
| 41,009,707 | Exploring the Anti-Inflammatory Activity of the Heat-Processed Gynostemma pentaphyllum Extract (Actiponin®) in RAW264.7 Cells and Carrageenan-Induced Rat Models. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009707 | PubMed |
| 40,330,076 | Promising impacts of Achillea spp., beyond A medicinal plant, against toxins, toxicities, and injuries: In vivo and in vitro mechanisms. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40330076 | PubMed |
| 39,910,080 | Therapeutic anti-inflammatory immune potentials of some seaweeds extracts on chemically induced liver injury in mice. | Sci Rep | 2025 | https://conductscience.org/library/papers/39910080 | PubMed |
| 38,497,028 | Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents. | ACS Omega | 2024 | https://conductscience.org/library/papers/38497028 | PubMed |
| 37,698,622 | Peroxisome proliferator activated receptor-gamma (PPAR-γ) ligand, pioglitazone, increases analgesic and anti-inflammatory effects of naproxen. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37698622 | PubMed |
| 37,448,842 | Papaver rhoeas L. stem and flower extracts: Anti-struvite, anti-inflammatory, analgesic, and antidepressant activities. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37448842 | PubMed |
| 37,110,650 | Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. | Molecules | 2023 | https://conductscience.org/library/papers/37110650 | PubMed |
| 36,590,508 | Pharmacodynamics and acute toxicity studies of Shangke Jiegu tablet with or without cinnabar. | Heliyon | 2022 | https://conductscience.org/library/papers/36590508 | PubMed |
| 36,512,053 | Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment of inflammatory arthritis owing to its NF-κB1 inhibitory potential. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36512053 | PubMed |
| 36,500,230 | Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies. | Molecules | 2022 | https://conductscience.org/library/papers/36500230 | PubMed |
| 36,230,218 | Investigation of Chemical Compounds and Evaluation of Toxicity, Antibacterial, and Anti-Inflammatory Activities of Three Selected Essential Oils and Their Mixtures with Moroccan Thyme Honey. | Foods | 2022 | https://conductscience.org/library/papers/36230218 | PubMed |
| 35,882,745 | The anti-inflamatory effect of Andira anthelmia lectin in rats involves inhibition of the prostanoid pathway, TNF-α and lectin domain. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35882745 | PubMed |
| 35,429,318 | Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35429318 | PubMed |
| 35,408,503 | Enhancement of the Anti-Inflammatory Activity of NSAIDs by Their Conjugation with 3,4,5-Trimethoxybenzyl Alcohol. | Molecules | 2022 | https://conductscience.org/library/papers/35408503 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5776026
GET https://conductscience.org/api/papers/v1/5776026/cited_by?page=2